Gwo Xi Stem Cell Company has established the R&D center for cell therapy development since 2011. We are committed to developing stem cell medicines that have the potential to help patients with unmet medical needs. Our production platform fully comply with medical regulations (Good Tissue Practice, GTP) in Taiwan. We have three clinical trials are ongoing in Taiwan, and one clinical trial is ongoing in Vietnam by now. In the future, we will have established the PIC/S GMP grade stem cell preparation factory (15,225 m2 built-out space) in Hsinchu Biomedical Science Park in Taiwan to put stem cell-based medicinal products into practice.